Diagnosed prevalent cases of primary open-angle glaucoma to reach 10 mn in 7MM by 2033 GlobalData Oct 31, 2024 GlobalData’s latest report reveals that the increase is partly attributed to increased disease awareness and improved diagnostic…
Gland Pharma receives tentative USFDA approval for Latanoprostene Bunod Ophthalmic Solution EP News Bureau Jul 23, 2024 According to IQVIA, the product had US sales of approximately $ 153 million for the twelve months ended December 2023
SPARC declares positive results from Phase 3 clinical trial of PDP-716 to treat open-angle glaucoma… EP News Bureau May 14, 2021 The primary endpoint of the trial was to evaluate the efficacy of once daily (QD) dosing of PDP-716 0.35 per cent compared with…
